Severe liver injury after initiating therapy with atomoxetine in two children
- PMID: 16769398
- DOI: 10.1016/j.jpeds.2006.01.035
Severe liver injury after initiating therapy with atomoxetine in two children
Abstract
Two children presented with acute hepatitis after starting therapy with atomoxetine (Strattera). In one child, no competing diagnosis could be identified, and liver injury resolved completely on withdrawal of the medication. In the second child, the evaluation was suggestive of type 1 autoimmune hepatitis; she subsequently improved with removal of atomoxetine and concomitant immunosuppressive therapy. Atomoxetine may cause clinically significant hepatotoxicity either by metabolic idiosyncrasy or by inducing autoimmune hepatitis.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical